Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Alexander J Eustace

16PUBLICATIONS

30CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer diagnosisPredictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Dec 20, 2025

Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients.

Charlotte Andrieu, Jojanneke Stoof, Dalal AlSultan

|Jun 05, 2025

TCHL - a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis.

John Crown, Alex J Eustace, Denis M Collins

|May 14, 2025

Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research's 60th Anniversary.

Seodhna M Lynch, Cathy E Richards, Aisling Ui Mhaonaigh

|Jun 19, 2024

Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference.

Seodhna M Lynch, Aisling B Heeran, Caoimbhe Burke

|Jan 11, 2024

CARBON DOTS: Bioimaging and Anticancer Drug Delivery.

Michał Bartkowski, Yingru Zhou, Mustafa Nabil Amin Mustafa

|Sep 27, 2023

Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.

Nicola Cosgrove, Alex J Eustace, Peter O'Donovan

Pageof 3

Frequent Collaborators

2 joint publications

Sinead Toomey

2 joint publications

Seodhna M Lynch

1 joint publications

Naomi Elster

1 joint publications

Kathy Gately

1 joint publications

Sandra Roche

1 joint publications

Michael J Duffy

1 joint publications

Denis M Collins

1 joint publications

Darran P O'Connor

1 joint publications

William M Gallagher

1 joint publications

Frankie A Holmes

Frequent Collaborators

2 joint publications

Sinead Toomey

2 joint publications

Seodhna M Lynch

1 joint publications

Naomi Elster

1 joint publications

Kathy Gately

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Published on : Aug 08, 2012

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

Published on : May 27, 2022

See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Published on : Aug 08, 2012

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

Published on : May 27, 2022

See more related videos